Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABBOTT LABORATORIES, INC. - POIN

UEI: L3AXXYLB3V56

ABBOTT LABORATORIES, INC. - POIN is a federal contractor, registered under UEI L3AXXYLB3V56. It has been awarded $313,562,340 across 71,413 federal contracts. Primary work spans Analytical Laboratory Instrument Manufacturing, Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, and Research and Development in Biotechnology. Top awarding agencies include Department Of Defense, Department Of Veterans Affairs, and 248-NETWORK Contract Office 8 (36C248).

Contact Information

Registration and classification details

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Abbott Laboratories Inc. specializes in the manufacturing and supply of in-vitro diagnostic substances, analytical laboratory instruments, and medical testing systems for government healthcare and defense operations. Their core capabilities center on point-of-care diagnostics, including cartridge-ba...

Abbott Laboratories Inc. specializes in the manufacturing and supply of in-vitro diagnostic substances, analytical laboratory instruments, and medical testing systems for government healthcare and defense operations. Their core capabilities center on point-of-care diagnostics, including cartridge-based analyzers, reagents, and consumables for clinical chemistry and immunoassay testing, with demonstrated expertise in deploying rapid diagnostic platforms such as i-STAT systems. They provide end-to-end solutions from diagnostic reagent formulation to instrument integration, supporting battlefield medicine, veterans’ health clinics, and military medical logistics. Technical strengths include assay development, regulatory-compliant manufacturing under GMP standards, and supply chain reliability for mission-critical diagnostic applications. The contractor maintains a dominant relationship with the Department of Defense, supplying diagnostic cartridges, analyzers, and medical consumables essential for field medical units and combat support hospitals. The Department of Veterans Affairs is a consistent partner, procuring point-of-care testing systems and reagents for VA medical centers, indicating a focus on decentralized, high-throughput clinical diagnostics. These relationships reflect a pattern of sustained, mission-aligned procurement for operational readiness and chronic disease monitoring in veteran populations. Industry focus is anchored in NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), with significant activity in medical wholesale distribution (423450). This positions Abbott Laboratories as a vertically integrated provider bridging diagnostic reagent production, instrument deployment, and logistics support—serving the defense and veteran healthcare markets with FDA-regulated, CLIA-compliant diagnostic solutions. As a 2L entity headquartered in North Chicago, Illinois, Abbott Laboratories Inc. operates as a large-scale manufacturer with established federal supply chain infrastructure. While no government certifications are listed, their consistent award history reflects compliance with federal procurement standards for medical devices and diagnostic products. Their geographic presence supports national defense and VA logistics networks through centralized manufacturing and distribution capabilities.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Department Of Defense$162.8M51.9%
Department Of Veterans Affairs$142.9M45.6%
248-NETWORK Contract Office 8 (36C248)$2.8M0.9%
Department Of Health And Human Services$2.3M0.8%
Other agencies (10 agencies, <0.5% each)$2.7M0.9%
Awards by NAICS
334516 - Analytical Laboratory Instrument Manufacturing$95.0M30.3%
423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers$64.2M20.5%
541711 - Research and Development in Biotechnology$45.0M14.4%
325412 - Pharmaceutical Preparation Manufacturing$39.7M12.7%
541714 - Research and Development in Biotechnology (except Nanobiotechnology)$37.6M12%
325413 - In-Vitro Diagnostic Substance Manufacturing$16.2M5.2%
325411 - Medicinal and Botanical Manufacturing$6.7M2.1%
339112 - Surgical and Medical Instrument Manufacturing$2.1M0.7%
811219 - Other Electronic and Precision Equipment Repair and Maintenance$1.8M0.6%
334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing$1.8M0.6%
Others - Other NAICS codes (20 codes, <0.5% each)$3.4M1.1%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABBOTT LABORATORIES, INC. - POIN's top NAICS codes and agencies

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

about 14 hours ago

DEADLINE

N/A
View Details
NAICS: 334516
New
Federal
Digital Trace Oxygen Analyzer
Solicitation # FA860126Q0034
The U.S. Air Force is soliciting a single Digital Trace Oxygen Analyzer under solicitation FA860126Q0034 for use in testing trace levels of oxygen in Nitrogen, Helium, Hydrogen, and Argon gas samples at the Aerospace Fuels Laboratory at Vandenberg Air Force Base, California. The requirement is set for full and open competition under NAICS code 334516 with no set-aside, and offers are due by 1:00 PM ET on August 20, 2026. Quotations must be submitted electronically via email to the specified contract specialists, contain the exact subject line, and be under five megabytes without compressed files or executable attachments; only PDF, DOC, DOCX, XLS, or XLSX formats are permitted. All submissions must include a fully completed Required Information Sheet, detailed supply description, and aggregate pricing for base and any option years, with all amounts in whole dollars. Submitters must be currently registered in SAM.gov, maintain an up-to-date registration within the past 12 months, and self-certify compliance with CMMC Level 1 requirements for safeguarding Federal Contract Information by documenting this in the Supplier Performance Risk System. Failure to meet these requirements will result in non-responsiveness regardless of other submission completeness. The contractor is prohibited from including customs duties in the quoted price, as the government will facilitate duty-free entry for eligible items. Delivery must occur within 12 weeks of contract award, and offerors must hold their prices firm for 60 days after the submission deadline. The government reserves the right to cancel the solicitation, conduct negotiations, or make no award based on quotation quality and price reasonableness.
FA8601 Aflcmc Pzio

POSTED

about 14 hours ago

DEADLINE

in about 15 hours
View Details